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Abstract 
The exceptional accessibility of the cervix (cervix uteri) and direct physical examination have allowed intensive 
research into the nature of the malignant lesions of the cervix. Studies have shown that many of these tumors have no 
explosive but gradual onset. Their pre-invasive antecedents may persist for two-way surfaces or in situ disease for 
several years, although this may change, at least in some patients. There is convincing evidence that the cytological 
screening programs are effective in reducing mortality from cervical cancer. Screening has not only reduced the 
incidence and mortality rate but has also found many women with pre-invasive neoplasia (which is the role of screening 
rather than diagnosing cancer). From the results of the Institute of Public Health of the Republic of Northern Macedonia 
for two years 2016 and 2017, it is concluded that the cervical cancer mortality rate in 2016 is significantly higher than 
in 2017, where the screening program is more developed and higher and there’s more coverage of at-risk patient group 
(50+ years). In 2016, 87.4% had normal results, while 12.6% had cellular abnormalities, compared to 2017 - 76.2% had 
normal results, while 23.8% had cellular abnormalities. The mortality rate in 2017 from cervical cancer is 30 which is 
lower than in 2016. This situation points to the necessity of increasing the coverage of women in the Program for 
screening and promoting the implementation of the Program by the Ministry of Health as soon as possible.  
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1. Introduction
Cervical cancer is a malignant neoplasm of the cervix or cervical surface. Cervical cancer is the second most common 
type of cancer in women worldwide and is associated with sexually transmitted genital infections, namely human 
papillomavirus (HPV). Cervical cancer can be considered a "controlled" cancer. It is preceded by a recognizable lesion 
(cervical intraepithelial neoplasia, CIN) that may (but not always) progress to invasive cancer. Targeted education, 
screening, and intervention can reduce the burden of disease. CIN can be treated with simple and effective treatments, 
including cryotherapy, laser ablation, electrosurgical loop excision (LEEP), and cold knife cone biopsy, all of which have 
a high cure rate. 
Risk factors for cervical cancer include numerous sexual partners, but increased data show that women may be at 
increased risk for their sexual partner, where her partner's sexual history is also extremely important. Persistent HPV 
infection increases the risk of progressive or persistent cervical dysplasia. Higher incidence of HPV infection and 
progression of intraepithelial neoplasia is seen in immunosuppressive patients, including those infected with HIV, as 
well as those undergoing organ transplantation, those with chronic renal failure, or a history of Hodgkin’s lymphoma. 
Smoking is now also considered a high-risk factor for cervical cancer. Individuals may be genetically predisposed to 
cervical cancer, but the relative risks are small. 
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For the diagnosis of cervical cancer is applied colposcopy, a colposcopic examination of the female genital tract does not 
take more than a few minutes, cytological screening, colposcopically targeted biopsies, ESS and pelvic examination. 
Therapy is indicated for women with CIN 2 or CIN 3. This also applies to those women with CIN 1. Treatment includes 
observation, local excision, electrocautery, cryosurgery, laser, cold coagulation, electrosurgical excision procedure 
(LEEP), conization, hysterectomy. No therapy is 100% effective, and the relationship between the patient's benefit and 
risk should be explained so that she is fully informed. For recurrent and advanced cervical cancer as therapy is applied 
- radical hysterectomy, radiation, chemotherapy. Symptoms of advanced cervical cancer may include: loss of appetite, 
weight loss, fatigue, pelvic pain, back pain, leg pain, unilateral swollen leg, heavy vaginal bleeding, leaking urine, or 
vaginal stools and bone fractures. [1-8].  
2. Material and methods 
Archival data has been used for statistics at the level of the whole country from the Institute of Public Health of the 
Republic of Northern Macedonia (RNM) in a period of 2 years - 2016 and 2017. Data were taken on the total number of 
patients and deceased by age, as well as the number of patients with abnormal PAP swabs. A consultation was made in 
order to be more informed about the disease with specialist doctors – gynecologists, statistics have been made on the 
number of deceased from cervical cancer in the Republic of Northern Macedonia in the period 2008-2017, emphasizing 
the importance of PAP screening and its application in RNM for the period 2012-2018.  
3. Results and discussion 
In the Republic of Northern Macedonia, a Program for Early Detection and Prevention of Cervical Cancer in Women has 
been implemented since 2007, through which a free Pap test was provided nationwide for all women aged 24-65. From 
2009 to 2011 in the Republic of Macedonia was conducted pilot cervical cancer screening in 4 pilot municipalities 
(Prilep, Gostivar, Stip and Sveti Nikole) for all women aged 30-55 years. In 2012, organized cervical cancer screening 
was started in the Republic of Macedonia for all women aged 24-35. In 2012, the Government of the Republic of 
Macedonia adopted a Program for early detection of malignant diseases, which started on 01.04.2012. Statistics from 
the Institute of Public Health of the Republic of Northern Macedonia in the period 2016-2017 are presented separately.  
Table 1 Cervical Cancer Screening Results in the Republic of Northern Macedonia for 2016 
Cancer type 2016 y. 
Squamous cell carcinoma suspected of invading 3 
Invasive squamous cell carcinoma 2 
Adenocarcinoma in situ 0 
Cervical adenocarcinoma 1 
Adenocarcinoma not otherwise specified NOS 0 
Another malignant neoplasm 0 
Normal results were obtained in 87.4%, while cellular abnormalities were detected in 12.6% of the cases. The screening 
revealed 6 cases of cancer, of which 3 squamous cell carcinoma suspected of invasion, 2 invasive squamous cell 
carcinoma, and 1 case of cervical adenocarcinoma. Of the total number of pathological lesions, the most common are 
CIN 1 (40.4%), HPV (33%) and ASCUS (15.3%). 
Table 2 Cervical Cancer Screening Results in the Republic of Northern Macedonia for 2017. 
Cancer type 2017 y. 
Squamous cell carcinoma suspected of invading 16 
Invasive squamous cell carcinoma 8 
Adenocarcinoma in situ 4 
Cervical adenocarcinoma 0 
Adenocarcinoma not otherwise specified NOS 12 
Another malignant neoplasm 8 
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Normal results were obtained in 76.2%, while cellular abnormalities were detected in 23.8%. The screening revealed 
48 cases of cancer, of which 16 squamous cell carcinoma suspected of invasion, 8 invasive squamous cell carcinoma, 4 
adenocarcinoma in situ, 2 adenocarcinoma not otherwise specified NOS and 18 other malignant neoplasms. Of the total 
number of pathological lesions, the most common are CIN 1 (44.4%), HPV (38%) and ASCUS (19.3%). 
 
Figure 1 Total abnormal cervical screening results in the Republic of Northern Macedonia for2016 and 2017 
Table 3 Deceased from cervical cancer in 2016 by age; rate per 100,000 women 4.54. 
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Table 4 Deceased from cervical cancer in 2017 by age; rate per 100,000 women: 2,89 
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Figure 2 Total cervical cancer deaths in 2016 and 2017 by age 
 
World Journal of Advanced Research and Reviews, 2020, 07(02), 200–205 
203 
 
Table 5 Total number of deaths from cervical cancer in the period 2008-2017 in the Republic of Northern Macedonia 
Year Total number of deaths Rate of 10000 
2008 43 4,21 
2009 35 3,42 
2010 31 3,02 
2011 15 1,46 
2012 39 3,79 
2013 36 3,49 
2014 42 4,07 
2015 39 3,77 
2016 47 4,54 
2017 30 2,89 
 
Starting from 2012 until today, there is a positive trend in the number of women covered by screening. 
 
Figure 3 Total number of deaths from cervical cancer in the period 2008-2017 in the Republic of Northern Macedonia 
Table 6 Number of PAP tests performed through organized screening in RSM for the period 2012-2018. 
Year Number of PAP tests 
2012 17595 
2013 20612 
2014 26270 
2015 29887 
2016 29118 
2017 27138 
Јануари- септември 2018 31630 
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Figure 4 Number of PAP tests performed through organized screening in RNM for the period 2012-2018 
According to the data taken from the Institute of Public Health of the Republic of Northern Macedonia, it can be 
concluded that over the years mortality from cervical cancer is declining. According to the data and the comparison 
between the two years 2016 and 2017, the importance of screening for early detection of abnormalities in women can 
be seen. In 2016, 87.4% received normal results, while 12.6% had cellular abnormalities, compared to 2017 - 76.2% 
received normal results, while 23.8% had cellular abnormalities. Screening in 2016 revealed 6 cases of cancer of which 
3 squamous cell carcinoma suspected of invasion, 2 invasive squamous cell carcinoma, and 1 case of cervical 
adenocarcinoma but there are a large number of women in the risk group (50+ years and other risk factors) as well as 
insufficiently informed women who did not attend the examination and who did not have a PAP test, therefore the 
mortality in the same year is 47, compared to 2017 when normal results were detected in 76.2%, while cellular 
abnormalities were detected in 23.8%, of which 48 cases of cancer were detected by screening, of which 16 squamous 
cell carcinoma suspected of invasion, 8 invasive squamous cell carcinoma, 4 adenocarcinoma in situ, 2 adenocarcinoma 
not otherwise specified NOS and 18 other malignant neoplasms. The mortality rate in 2017 from cervical cancer is 30 
and is lower than in 2016, so that within the organized screening in 2017, 27,138 women aged 46 to 60 were 
preventively examined, as well as the age groups that did not have a Pap smear in 2016. This is due to the greater 
awareness of women about the importance of screening as prevention of their health, which is confirmed by the number 
of screening examinations performed from January to September 2018, which is the highest so far and is 31,630. 
4. Conclusion 
With proper prevention, early detection of precancerous lesions can control the disease and significantly reduce 
mortality. The Ministry of Health of the Republic of Northern Macedonia follows the trends of the developed countries 
in the field of reproductive health, respecting the three principles for protection of women's health through: 
 Introduction of HPV vaccination in the regular immunization calendar 
 Organized screening - regular gynecological examinations with free PAP – test 
 Early detection and treatment of cervical cancer 
By increasing the level of knowledge and informing women (target group) about the disease and the need to perform 
preventive examinations and to motivate them to perform the examination, there is a timely detection and treatment of 
the disease and thus reduce mortality.  
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Statement of informed consent 
Informed consent was obtained from the participant included in the study. 
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